National Pharmaceutical Council achieved Great Place To Work Certification for a third consecutive year.
Public source
Publisher name
Public post
I say it often: our team at the National Pharmaceutical Council is the best. Our people are talented. They’re curious. They care about our work and about each other. As…
Company
National Pharmaceutical Council
Policy-relevant research since 1953
- Industry
- Pharmaceutical Manufacturing
- Location
- Washington, US
- Company size
- 11–50 employees
About National Pharmaceutical Council
NPC serves patients and society with policy-relevant research on the value of patient access to innovative medicines and the importance of scientific advancement. We envision a world where advances in medicine are accessible to patients, valued by society, and sustainably reimbursed by payers to ensure continued innovation. We provide the evidence to bolster the case for the value of innovation through our policy-relevant research. NPC informs policy discussions in the media, in Congressional testimony, and through leading voices sharing our research about the future of innovative medicine and patient access.
See moreLatest activity
Latest activity from National Pharmaceutical Council
7 signals
Research & Knowledge
National Pharmaceutical Council published a guide explaining the risks of Upper Payment Limit (UPL) implementation, what's at stake, and the current landscape.
Presence & Recognition
National Pharmaceutical Council President and CEO John O'Brien will join Christie Bloomquist of Boehringer Ingelheim, Samaneh K. of Zealand Pharma, and Ryan Urgo of Eli Lilly and Company for a conversation on
Presence & Recognition
National Pharmaceutical Council President and CEO John O'Brien will join Chris Pernie of Novo Nordisk, Jen Dial of Roche Diagnostics USA, Christian Emering of Harmony Biosciences, and Ryan Kuresman of GCI Health for the panel session at FiercePharmaWeek in Philadelphia on Tuesday, September 15.
Discover more
Similar signals
Similar public activity from other companies.
Legal & Regulatory
Medication Management Partners
Medication Management Partners was Great Place to Work® Certified for the seventh consecutive year.
Legal & Regulatory
SPI Pharma
SPI Pharma's strategic manufacturing partner Q-VANT Biosciences achieved EXCiPACT certification for pharmaceutical excipient quality and GMP compliance.
Legal & Regulatory
National Health Care Associates
National Health Care Associates achieved Great Place To Work certification for three consecutive years.
Legal & Regulatory
PhRMA
PhRMA noted that in October 2025, the FDA approved a breakthrough treatment for pulmonary fibrosis, allowing patients in the United States to access it quickly.
Legal & Regulatory
Bristol Myers Squibb UK & Ireland